In addition, we discuss the potential of the Hv1 channel as a relevant therapeutic target for the development of anti-cancer drugs; thus, this protein could establish a common aim for many types of solid tumors, paving a strong strategy against tumors. This evidence concerns the gene HVCN1 and cancer.